A biotechnology startup in Bengaluru is developing an experimental “liquid cornea” hydrogel therapy designed to repair damaged corneal tissue and potentially reduce the need for donor corneal transplants.
The treatment uses a bioengineered hydrogel biomaterial that is applied to the damaged cornea. When exposed to light, it solidifies and forms a transparent scaffold that supports cell growth and tissue regeneration.
This innovation is significant because corneal blindness affects millions worldwide, and there is a major shortage of donor corneas, with only about one donor cornea available for every 70 patients who need a transplant.
If successful, such regenerative therapies could transform how corneal injuries and diseases are treated.
I think, to increase the donors, lot of awareness camps be conducted bit more often like every other camps, and that is the only option is available I think.
This is a truly exciting development in regenerative ophthalmology. A “liquid cornea” hydrogel that solidifies into a transparent scaffold could dramatically reduce dependence on donor transplants.
Such innovative startups would definitely bring a breakthrough in achieving independence on traditional transplants of other organs or delicate tissues requiring a successive donor person. I hope more regenerative therapies may develop in future for solving this real challenging question in front of current healthcare professionals.
This is a really promising innovation in regenerative medicine. The idea of using a bioengineered hydrogel to support corneal repair could potentially address the major shortage of donor corneas and improve accessibility to treatment. It’s exciting to see biotechnology creating such practical solutions for vision restoration.
Read the full article: